| # | Drug | Count |
|---|---|---|
| 0 | RIVAROXABAN | 163 |
| 1 | ASPIRIN | 44 |
| 2 | ASPIRIN 325 MG | 43 |
| 3 | ASPIRIN 81 MG | 43 |
| 4 | DABIGATRAN ETEXILATE | 40 |
| 5 | DABIGATRAN ETEXILATE MESYLATE | 40 |
| 6 | APIXABAN | 36 |
| 7 | PREDNISOLONE | 29 |
| 8 | PREDNISOLONE ORAL | 29 |
| 9 | PREDNISOLONE ORAL SOLUTION | 29 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TEDIZOLID PHOSPHATE | 10 | 0.0125 |
| 1 | ANDEXANET ALFA | 8 | 0.0113 |
| 2 | ETHIODIZED OIL | 9 | 0.0069 |
| 3 | MEXILETINE HYDROCHLORIDE | 2 | 0.0048 |
| 4 | BENZOCAINE AND DEXTROMETHORPHAN HYDROBROMIDE | 1 | 0.0040 |
| 5 | BENZOCAINE AND MENTHOL | 1 | 0.0038 |
| 6 | FLUMAZENIL | 3 | 0.0034 |
| 7 | BETHANECHOL CHLORIDE | 1 | 0.0018 |
| 8 | EDOXABAN TOSYLATE | 11 | 0.0016 |
| 9 | CETYLPYRIDINIUM CHLORIDE | 1 | 0.0015 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Benzodiazepine Antagonist [EPC] | 3 | 0.0034 |
| 1 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 2 | 0.0009 |
| 2 | Lymphocyte Growth Factor [EPC] | 1 | 0.0008 |
| 3 | Factor Xa Inhibitor [EPC] | 196 | 0.0007 |
| 4 | Blood Viscosity Reducer [EPC] | 3 | 0.0007 |
| 5 | Claudin 18.2-directed Cytolytic Antibody [EPC] | 1 | 0.0007 |
| 6 | Lipid-based Polyene Antifungal [EPC] | 8 | 0.0006 |
| 7 | Endoglycosidase [EPC] | 1 | 0.0005 |
| 8 | Interferon alfa-2b [EPC] | 1 | 0.0005 |
| 9 | Amyloid Beta-directed Antibody [EPC] | 2 | 0.0005 |